These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 14551573)
41. Role of rho-kinase activity in angiotensin II-induced contraction of rabbit clitoral cavernosum smooth muscle. Park JK; Lee SO; Kim YG; Kim SH; Koh GY; Cho KW Int J Impot Res; 2002 Dec; 14(6):472-7. PubMed ID: 12494280 [TBL] [Abstract][Full Text] [Related]
42. Counterpoint: release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase-mediated calcium sensitization of smooth muscle cell contraction are not the main effectors for full and sustained HPV. Rochefort GY; Michelakis ED J Appl Physiol (1985); 2007 May; 102(5):2072-5; discussion 2075, 2080. PubMed ID: 17483441 [No Abstract] [Full Text] [Related]
43. Y-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNo and the Rho-kinase pathways. Gao BH; Zhao ST; Meng FW; Shi BK; Liu YQ; Xu ZS Andrologia; 2007 Aug; 39(4):146-50. PubMed ID: 17683464 [TBL] [Abstract][Full Text] [Related]
44. Microtubule depolymerization facilitates contraction of vascular smooth muscle via increased activation of RhoA/Rho-kinase. Chitaley K; Webb RC Med Hypotheses; 2001 Mar; 56(3):381-5. PubMed ID: 11359365 [TBL] [Abstract][Full Text] [Related]
45. The RhoA/Rho kinase pathway in the myocardium. Peters SL; Michel MC Cardiovasc Res; 2007 Jul; 75(1):3-4. PubMed ID: 17499228 [No Abstract] [Full Text] [Related]
46. Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Chang S; Hypolite JA; Changolkar A; Wein AJ; Chacko S; DiSanto ME Int J Impot Res; 2003 Feb; 15(1):53-62. PubMed ID: 12605241 [TBL] [Abstract][Full Text] [Related]
47. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats. Wilkes N; White S; Stein P; Bernie J; Rajasekaran M Int J Impot Res; 2004 Apr; 16(2):187-94. PubMed ID: 15073608 [TBL] [Abstract][Full Text] [Related]
48. Role of the RhoA/Rho-kinase pathway in the regulation of pulmonary vasoconstrictor function. Nossaman BD; Nossaman VE; Murthy SN; Kadowitz PJ Can J Physiol Pharmacol; 2010 Jan; 88(1):1-8. PubMed ID: 20130732 [TBL] [Abstract][Full Text] [Related]
54. Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Lee DL; Webb RC; Jin L Hypertension; 2004 Dec; 44(6):796-9. PubMed ID: 15520302 [TBL] [Abstract][Full Text] [Related]
55. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. Calò LA; Pessina AC J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228 [TBL] [Abstract][Full Text] [Related]
56. Role of Rho kinase signalling in healthy and varicose human saphenous veins. Cario-Toumaniantz C; Evellin S; Maury S; Baron O; Pacaud P; Loirand G Br J Pharmacol; 2002 Sep; 137(2):205-12. PubMed ID: 12208777 [TBL] [Abstract][Full Text] [Related]
57. Activation of Rho signaling contributes to lysophosphatidic acid-induced contraction of intact ileal smooth muscle of guinea-pig. Mori M; Tsushima H Can J Physiol Pharmacol; 2000 Sep; 78(9):729-36. PubMed ID: 11007536 [TBL] [Abstract][Full Text] [Related]
58. Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Jackson EK; Gillespie DG; Zhu C; Ren J; Zacharia LC; Mi Z Hypertension; 2008 Mar; 51(3):719-26. PubMed ID: 18250367 [TBL] [Abstract][Full Text] [Related]
59. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension. Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956 [TBL] [Abstract][Full Text] [Related]
60. Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Chang S; Hypolite JA; Zderic SA; Wein AJ; Chacko S; Disanto ME Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R1124-30. PubMed ID: 15961528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]